This Contract Research Company Reports 31 Per Cent Q4 Revenue Growth, Declares Rs 2 Dividend, Proposes 1:1 Bonus Share Issue, and Announces Entry Into Biologics R&D Services Expansion This Contract Research Company Reports 31 Per Cent Q4 Revenue Growth, Declares Rs 2 Dividend, Proposes 1:1 Bonus Share Issue, and Announces Entry Into Biologics R&D Services Expansion Over the past six months, the stock has surged 86 per cent, and it has delivered over 1,100 per cent returns in the past five years. DSIJ Intelligence-2 / Tuesday, April 29, 2025 / Article rating: 5.0 Over the past six months, the stock has surged 86 per cent, and it has delivered over 1,100 per cent returns in the past five years.